ストックスクリーナーアプリを入手
86.22
3.56%
2.96
アフターアワーズ：
85.89
-0.33
-0.38%
前日終値:
$83.26
開ける：
$83.6
24時間の取引高:
178.00K
Relative Volume:
1.19
時価総額：
$843.85M
収益：
-
当期純損益:
$-14.23M
株価収益率:
-44.45
EPS:
-1.9396
ネットキャッシュフロー:
$-9.44M
1週間 パフォーマンス:
-3.11%
1か月 パフォーマンス:
+20.65%
6か月 パフォーマンス:
+65.27%
1年 パフォーマンス:
+176.26%
1日の値動き範囲:
$81.35
$87.36
1週間の範囲:
$81.29
$91.00
52週間の値動き範囲:
$23.18
$123.75
Bright Minds Biosciences Inc Stock (DRUG) Company Profile
Compare DRUG vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DRUG
Bright Minds Biosciences Inc
|
86.22 | 814.88M | 0 | -14.23M | -9.44M | -1.9396 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 109.34B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 74.35B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 50.44B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 39.78B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.02B | 5.36B | 287.73M | 924.18M | 2.5229 |
Bright Minds Biosciences Inc Stock (DRUG) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-13 | 開始されました | Jefferies | Buy |
| 2025-09-08 | 開始されました | BTIG Research | Buy |
| 2025-05-13 | 開始されました | TD Cowen | Buy |
| 2025-05-07 | 開始されました | Chardan Capital Markets | Buy |
| 2025-01-23 | 開始されました | Piper Sandler | Overweight |
| 2025-01-10 | 開始されました | Cantor Fitzgerald | Overweight |
| 2025-01-10 | 開始されました | H.C. Wainwright | Buy |
| 2024-11-26 | 開始されました | Robert W. Baird | Outperform |
すべてを表示
Bright Minds Biosciences Inc (DRUG) 最新ニュース
This Insider Has Just Sold Shares In Bright Minds Biosciences - simplywall.st
DRUG SEC FilingsBright Minds Biosciences Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Cormorant sells $9.78m in Bright Minds Biosciences stock - Investing.com UK
[SCHEDULE 13G/A] BRIGHT MINDS BIOSCIENCES INC. Amended Passive Investment Disclosure - Stock Titan
Insider Selling: Bright Minds Biosciences (NASDAQ:DRUG) Major Shareholder Sells 109,331 Shares of Stock - MarketBeat
Bright Minds Biosciences (DRUG) holder sells 109,331 shares in open market - Stock Titan
Bright Minds announces ATM offering up to $100 million - MSN
How Bright Minds Biosciences Inc. (DRUG) Affects Rotational Strategy Timing - Stock Traders Daily
Bright Minds (DRUG) Year-Ahead Outlook | Q4 2025: Earnings ReportSurprise Score - Cổng thông tin điện tử tỉnh Tây Ninh
Bright Minds Biosciences Inc. (NASDAQ:DRUG) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Top 3 Canadian Biotech Stocks in 2026 - Investing News Network
Bright Minds Biosciences (NASDAQ:DRUG) Downgraded to Sell Rating by Wall Street Zen - MarketBeat
Shroom stocks rise as Trump is said to sign executive order on psychedelic drug - Seeking Alpha
Bright Minds Biosciences Inc. (NASDAQ:DRUG) Sees Significant Growth in Short Interest - MarketBeat
(DRUG) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Bright Minds Biosciences (NASDAQ:DRUG) Earns Buy Rating from Analysts at Jefferies Financial Group - MarketBeat
Jefferies initiates Bright Minds stock with buy on epilepsy drug By Investing.com - Investing.com South Africa
Jefferies initiates Bright Minds stock with buy on epilepsy drug - Investing.com
Total debt per share of Bright Minds Biosciences Inc. – NEO:DRUG - TradingView
Certain RSUs of Bright Minds Biosciences Inc. are subject to a Lock-Up Agreement Ending on 8-APR-2026. - marketscreener.com
Certain Options of Bright Minds Biosciences Inc. are subject to a Lock-Up Agreement Ending on 8-APR-2026. - marketscreener.com
7,787,161 Common Shares of Bright Minds Biosciences Inc. are subject to a Lock-Up Agreement Ending on 8-APR-2026. - marketscreener.com
Bright Minds Biosciences (NASDAQ:DRUG) Shares Gap UpHere's Why - MarketBeat
Pullback Watch: Is Bright Minds Biosciences Inc a cyclical or defensive stockRecession Risk & Target Return Focused Stock Picks - baoquankhu1.vn
Bright Minds Biosciences (NASDAQ:DRUG) Trading 7.4% HigherWhat's Next? - MarketBeat
Sentiment Watch: What is PROVs 5 year growth outlookWeekly Profit Recap & Proven Capital Preservation Methods - baoquankhu1.vn
Responsive Playbooks and the DRUG Inflection - Stock Traders Daily
Bright Minds Biosciences Inc. (DRUG.NE) interactive stock chart - Yahoo Finance UK
Bright Minds Biosciences Inc. (DRUG.NE) Stock Forum & Discussion - Yahoo! Finance Canada
Bright Minds Biosciences Inc Live Share Prices and Trades. DRUG.US Live Streaming Share Prices. - London South East
Swing Trade: Whats the profit margin of WB PRCCLTrade Exit Report & Community Verified Watchlist Alerts - baoquankhu1.vn
Bright Minds Biosciences (NASDAQ:DRUG) Given Buy Rating at BTIG Research - Defense World
Bright Minds Biosciences (NASDAQ:DRUG) Earns Buy Rating from BTIG Research - MarketBeat
BTIG reiterates Bright Minds Biosciences stock rating on seizure treatment potential - Investing.com India
What is the probability of success for Bright Minds Biosciences Inc (DRUG)’s lead drug candidate? - msn.com
Bright Minds Biosciences Inc. (NASDAQ:DRUG) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Bright Minds Biosciences Inc. (NASDAQ:DRUG) Receives Average Recommendation of “Moderate Buy” from Brokerages - defenseworld.net
Hedge Fund Bets: How much upside does Bright Minds Biosciences Inc have2026 Macro Moves & Weekly Top Stock Performers List - baoquankhu1.vn
What Is the Probability of Success for Bright Minds Biosciences Inc (DRUG)’s Lead Drug Candidate? - Yahoo Finance
Understanding the Setup: (DRUG) and Scalable Risk - Stock Traders Daily
Bright Minds Biosciences (NASDAQ:DRUG) Raised to "Hold" at Wall Street Zen - MarketBeat
Risk Off: Is PMTPRC showing insider buying2026 Decliners & Trade Opportunity Analysis Reports - baoquankhu1.vn
Pullback Watch: Is Bright Minds Biosciences Inc undervalued by DCF analysis2026 Price Momentum & Expert Approved Momentum Ideas - baoquankhu1.vn
303,685 Shares in Bright Minds Biosciences Inc. $DRUG Acquired by Braidwell LP - MarketBeat
Bright Minds Biosciences Inc (DRUG) 財務データ
収益
当期純利益
現金流量
EPS
0.14%
0.48%
大文字化:
|
ボリューム (24 時間):